Merck Establishes New Semiconductor Hub in Taiwan
Merck has opened a new semiconductor operations base in Taiwan, reinforcing the resilience of its global supply chain and strengthening its position within the semiconductor ecosystem.
The integrated facility will focus on semiconductor materials, especially thin-film materials. Driven by rapidly growing AI-related demand, Merck Electronics’ thin-film business achieved record sales in the third quarter of 2025. Thin-film technologies enable atomic-level material deposition and removal, supporting the creation of increasingly complex, multilayer chip architectures required for advanced semiconductor manufacturing.
“Our strategy is to stay close to our customers and align with their technology roadmaps. This investment secures our position in one of the world’s most strategically important semiconductor ecosystems,” said Kai Beckmann, Vice Chair of Merck’s Executive Board and CEO of the Electronics business sector. “The new site in Taiwan will support our long-term growth ambitions in electronics and expand our R&D and manufacturing capabilities.”
The Kaohsiung site spans 150,000 square meters and is Merck’s largest semiconductor materials production facility worldwide. It specializes in thin-film materials, formulated materials, and specialty gases essential for precision layering, etching, and patterning processes in modern semiconductor manufacturing. These materials are critical for producing cutting-edge logic and memory chips, particularly those used in AI applications. Merck’s “lab-to-fab and fab-to-lab” model enhances the local supply chain and fosters seamless collaboration between research labs and semiconductor fabs. The facility is scheduled to begin operations in 2026 and will create 150 new jobs in Kaohsiung.
Built to LEED Gold standards, the project incorporates advanced smart manufacturing technologies, including digital twins. These innovations improve accuracy and efficiency, streamline production processes, and enable predictive maintenance. Renewable energy will cover 50% of the site’s annual electricity consumption.
With this investment in Kaohsiung, Merck is nearing completion of its “Level Up” investment program announced in 2021. Over the past five years, Merck Electronics has invested more than €3 billion in innovation and capacity expansion. These efforts not only support customers’ growth plans but also strengthen the resilience of the global supply chain.
Looking for chemical products? Let suppliers reach out to you!
2026-07-15
-
Paint & Coating Industry Overview Mar.2025
This issue provides analysis of the European and German coatings markets, as well as the latest monthly reports and price trends of coatings-related chemical raw materials. Support online permanent download.Published in: Mar.2025
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Merck Completes Sale of Surface Solutions Business to GNMI for €665 Million
-
Merck and Siemens Collaborate on Smart Manufacturing
-
Merck sells Surface Solutions to Global New Material International for €665 million in cash
-
Merck Group acquires chip equipment supplier Unity-SC for €155 million
-
Merck Launches Commercial Production of First GMP-Compliant Cell Culture Media Production Line in China
-
Merck to acquire EyeBio for $3 billion
-
Circa signs OEM agreement with Merck to supply and sell Cyrene
-
The Rising Heat of DAC Drugs: ADC and PROTAC Sparking Innovation
-
Merck Expands Biosafety Testing Laboratory Center in Shanghai
-
Merck to Acquire Caraway Therapeutics in a $610 Million Deal
Recommend Reading
-
Toxic Ammonia Leak Prompts Emergency Response in Mississippi
-
China’s Titanium Dioxide Giant Makes a Move: LB Group Acquires UK Venator Assets
-
Evonik Achieves Successful Trial Production at Shanghai Polyamide Plant
-
When Light Falls on Metal: The Industrial Romance of Xiaomi × BASF
-
Lanxess Reports Challenging Third Quarter Amid Weak Global Demand and Geopolitical Uncertainty
-
Small Pharma Firms Under Threat as Regulator Tightens Quality Norms
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Biocon Weighs Merger of Biocon Biologics to Unlock Value
-
Sun Pharma’s Utreglutide Shows Promising Weight Loss and Liver Fat Reduction
-
Spain Authorizes Emergency Use of Sulfoxaflor Formulation to Combat Cabbage Whitefly Outbreak